Viewing Study NCT06926595


Ignite Creation Date: 2025-12-24 @ 1:57 PM
Ignite Modification Date: 2026-02-06 @ 12:34 PM
Study NCT ID: NCT06926595
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-04-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention
Sponsor: Milton S. Hershey Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graft-versus-Host Disease (GVHD) View
None Hematologic Malignancies View
None Allogeneic Stem Cell Transplantation View
Keywords: